IVF Hartmann Holding AG
SIX:VBSN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (9.8), the stock would be worth CHf159.86 (18% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.3 | CHf136 |
0%
|
| 3-Year Average | 9.8 | CHf159.86 |
+18%
|
| 5-Year Average | 11.4 | CHf185.52 |
+36%
|
| Industry Average | 17 | CHf277.33 |
+104%
|
| Country Average | 12.7 | CHf206.91 |
+52%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
|
IVF Hartmann Holding AG
SIX:VBSN
|
326.4m CHF | 8.3 | 17.8 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.4B USD | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 28.4 | 39.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.5B CHF | 14.9 | 38.9 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
98.2B DKK | 12.9 | 24.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.9B USD | 14.8 | 34 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.5B GBP | 11.9 | 34.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 16.9 | -15.7 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.4T KRW | -84.9 | -38 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
895.2B JPY | 23.9 | 50.6 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.3B USD | 14.5 | 22.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 9.2 |
| Median | 12.7 |
| 70th Percentile | 20.5 |
| Max | 1 129.6 |
Other Multiples
IVF Hartmann Holding AG
Glance View
IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. The company is headquartered in Neuhausen Am Rheinfall, Schaffhausen and currently employs 340 full-time employees. The company went IPO on 2012-07-16. The firm's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The firm also offers consulting services, on-site or in classrooms, related to the usage of its products. The firm's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. The company also operates subsidiaries located in Switzerland.
